CS logo
small CS logo
Toyota Memorial Hospital

Aichi Toyota, Japan

About Toyota Memorial Hospital


トヨタ記念病院は、愛知県豊田市にある医療機関。トヨタ自動車が運営する企業立病院である。地域周産期母子医療センター、救命救急センターなどの機能を有する。
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Chugai Pharmaceutical
2
AstraZeneca
1
Bayer
1
Kyowa Kirin Co., Ltd.
1
Ministry of Health, Labour and Welfare, Japan
1
Nagoya University
1
Total Rows: 7

Clinical Trials at Toyota Memorial Hospital


During the past decade, Toyota Memorial Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11002211113311110000000011001100Started TrialsCompleted Trails2015201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF)
2011-09-01
2016-12-01
Unknown status
1,000
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting
2015-12-18
2016-06-01
Completed
1,232
A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice
2017-07-01
2023-03-31
Recruiting
300
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)
2018-08-15
2021-07-08
Completed
1,026
KW-3357 Study in Patients With Early Onset Severe Preeclampsia
2019-11-19
2023-07-31
Recruiting
180
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Toyota Memorial Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Kyowa Kirin Co., Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Toyota Memorial Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Japan Blood Products Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 5Boehringer Ingelheim: 5Chugai Pharmaceutical: 2Chugai Pharmaceutical: 2AstraZeneca: 1AstraZeneca: 1Bayer: 1Bayer: 1Kyowa Kirin Co., Ltd.: 1Kyowa Kirin Co., Ltd.: 1Ministry of Health,Labour and Welfare,Japan: 1Ministry of Health,Labour and Welfare,Japan: 1Nagoya University: 1Nagoya University: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Japan Lung Cancer Society: 2Japan Lung Cancer Society: 2Japan Blood ProductsOrganization: 1Japan Blood ProductsOrganization: 1

Clinical Trials Conditions at Toyota Memorial Hospital


According to Clinical.Site data, the most researched conditions in "Toyota Memorial Hospital" are "Heart Failure" (2 trials), "Schizophrenia" (2 trials), "Asthma" (1 trials), "Atrial Fibrillation" (1 trials) and "Extensive Disease Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Toyota Memorial Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Toyota Memorial Hospital


Most popular intervention types in "Toyota Memorial Hospital" are "Drug" (7 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "ASA 100 mg" (1 trials), "Antithrombin gamma" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Toyota Memorial Hospital


The vast majority of trials in "Toyota Memorial Hospital" are 11 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Toyota Memorial Hospital


Currently, there are NaN active trials in "Toyota Memorial Hospital". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Toyota Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Toyota Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusRecruiting: 5Recruiting: 5Completed: 4Completed: 4Active, not recruiting: 2Active, not recruiting: 2Unknown status: 1Unknown status: 1